Ado-trastuzumab emtansine Intravenous and Stiolto Respimat
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Stiolto Respimat and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: olodaterol / tiotropium
Brand name: Stiolto Respimat, Stiolto Respimat 28 ACT, Stiolto Respimat 60 ACT, Stiolto Respimat 10 ACT
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Stiolto Respimat 28 ACT
- Ado-trastuzumab emtansine Intravenous-Stiolto Respimat 60 ACT
- Ado-trastuzumab emtansine Intravenous-Stiripentol
- Ado-trastuzumab emtansine Intravenous-Stiripentol Capsules
- Ado-trastuzumab emtansine Intravenous-Stiripentol Powder Packets
- Ado-trastuzumab emtansine Intravenous-Stivarga
- Stiolto Respimat-Adox Pak 2/100
- Stiolto Respimat-Adoxa
- Stiolto Respimat-Adoxa CK
- Stiolto Respimat-Adoxa Pak
- Stiolto Respimat-Adoxa Pak 1/100
- Stiolto Respimat-Adoxa Pak 1/150